Abstract
Fibroblasts in the heart play a critical function in the secretion and modulation of extracellular matrix critical for optimal cellular architecture and mechanical stability required for its mechanical function. Fibroblasts are also intimately involved in both adaptive and nonadaptive responses to cardiac injury. Fibroblasts provide the elaboration of extracellular matrix and, as myofibroblasts, are responsible for cross-linking this matrix to form a mechanically stable scar after myocardial infarction. By contrast, during heart failure, fibroblasts secrete extracellular matrix, which manifests itself as excessive interstitial fibrosis that may mechanically limit cardiac function and distort cardiac architecture (adverse remodeling). This review examines the hypothesis that fibroblasts mediating scar formation and fibroblasts mediating interstitial fibrosis arise from different cellular precursors and in response to different autocoidal signaling cascades. We demonstrate that fibroblasts which generate scars arise from endogenous mesenchymal stem cells, whereas those mediating adverse remodeling are of myeloid origin and represent immunoinflammatory dysregulation.
Similar content being viewed by others
References
Sun, Y., Kiani, M. F., Postlethwaite, A. E., & Weber, K. T. (2002). Infarct scar as living tissue. Basic Research in Cardiology, 97, 343–347.
Weber, K. T. (1989). Cardiac interstitium in health and disease: the fibrillar collagen network. Journal of the American College of Cardiology, 13, 1637–1652.
Bing, O. H., Matsushita, S., Fanburg, B. L., & Levine, H. J. (1971). Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circulation Research, 28, 234–245.
Jalil, J. E., Janicki, J. S., Pick, R., Abrahams, C., & Weber, K. T. (1989). Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circulation Research, 65, 258–264.
Thiedemann, K. U., Holubarsch, C., Medugorac, I., & Jacob, R. (1983). Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical, and mechanical parameters. Basic Research in Cardiology, 78, 140–155.
Weber, K. T., Brilla, C. G., & Janicki, J. S. (1993). Myocardial fibrosis: functional significance and regulatory factors. Cardiovascular Research, 27, 341–348.
Weber, K. T., Pick, R., Jalil, J. E., Janicki, J. S., & Carroll, E. P. (1989). Patterns of myocardial fibrosis. Journal of Molecular and Cellular Cardiology, 21(Suppl 5), 121–131.
Carlson, S., Trial, J., Soeller, C., & Entman, M. L. (2011). Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovascular Research, 91, 99–107.
Kalluri, R., & Neilson, E. G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. The Journal of Clinical Investigation, 112, 1776–1784.
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine, 13, 952–961.
Esposito, M. T., Di Noto, R., Mirabelli, P., Gorrese, M., Parisi, S., Montanaro, D., et al. (2009). Culture conditions allow selection of different mesenchymal progenitors from adult mouse bone marrow. Tissue Engineering. Part A, 15, 2525–2536.
Sarugaser, R., Hanoun, L., Keating, A., Stanford, W. L., & Davies, J. E. (2009). Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One, 4, e6498.
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine, 1, 71–81.
Pilling, D., Fan, T., Huang, D., Kaul, B., & Gomer, R. H. (2009). Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One, 4, e7475.
Abe, R., Donnelly, S. C., Peng, T., Bucala, R., & Metz, C. N. (2001). Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Journal of Immunology, 166, 7556–7562.
Yang, L., Scott, P. G., Giuffre, J., Shankowsky, H. A., Ghahary, A., & Tredget, E. E. (2002). Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Laboratory Investigation, 82, 1183–1192.
Hashimoto, N., Jin, H., Liu, T., Chensue, S. W., & Phan, S. H. (2004). Bone marrow-derived progenitor cells in pulmonary fibrosis. The Journal of Clinical Investigation, 113, 243–252.
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., et al. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. The Journal of Clinical Investigation, 114, 438–446.
Schmidt, M., Sun, G., Stacey, M. A., Mori, L., & Mattoli, S. (2003). Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. Journal of Immunology, 171, 380–389.
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., et al. (2005). CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. American Journal of Pathology, 166, 675–684.
Pilling, D., Buckley, C. D., Salmon, M., & Gomer, R. H. (2003). Inhibition of fibrocyte differentiation by serum amyloid P. Journal of Immunology, 171, 5537–5546.
Pilling, D., Tucker, N. M., & Gomer, R. H. (2006). Aggregated IgG inhibits the differentiation of human fibrocytes. Journal of Leukocyte Biology, 79, 1242–1251.
Shao, D. D., Suresh, R., Vakil, V., Gomer, R. H., & Pilling, D. (2008). Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. Journal of Leukocyte Biology, 83, 1323–1333.
Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. The Journal of Pathology, 214, 199–210.
Dewald, O., Frangogiannis, N. G., Zoerlein, M., Duerr, G. D., Klemm, C., Knuefermann, P., et al. (2003). Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proceedings of the National Academy of Sciences, USA, 100, 2700–2705.
Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., et al. (2006). Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proceedings of the National Academy of Sciences of the United States of America, 103, 18284–18289.
Dewald, O., Ren, G., Duerr, G. D., Zoerlein, M., Klemm, C., Gersch, C., et al. (2004). Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. American Journal of Pathology, 164, 665–677.
Frangogiannis, N. G., Mendoza, L. H., Lewallen, M., Michael, L. H., Smith, C. W., & Entman, M. L. (2001). Induction and suppression of interferon-inducible protein (IP)-10 in reperfused myocardial infarcts may regulate angiogenesis. The FASEB Journal, 15, 1428–1430.
Kukielka, G. L., Smith, C. W., LaRosa, G. J., Manning, A. M., Mendoza, L. H., Hughes, B. J., et al. (1995). Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. The Journal of Clinical Investigation, 95, 89–103.
Kumar, A. G., Ballantyne, C. M., Michael, L. H., Kukielka, G. L., Youker, K. A., Lindsey, M. L., et al. (1997). Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation, 95, 693–700.
Lakshminarayanan, V., Lewallen, M., Frangogiannis, N. G., Evans, A. J., Wedin, K. E., Michael, L. H., et al. (2001). Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. American Journal of Pathology, 159, 1301–1311.
Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., et al. (2007). Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation, 115, 584–592.
Frangogiannis, N. G., Ren, G., Dewald, O., Zymek, P., Koerting, A., Winkelmann, K., et al. (2005). Critical role of endogenous thrombospondin (TSP)-1 in preventing expansion of healing myocardial infarcts. Circulation, 111, 2935–2942.
Haudek, S. B., Trial, J., Xia, Y., Gupta, D., Pilling, D., & Entman, M. L. (2008). Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proceedings of the National Academy of Sciences of the United States of America, 105, 10179–10184.
Moreira, A. P., Cavassani, K. A., Hullinger, R., Rosada, R. S., Fong, D. J., Murray, L., et al. (2010). Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. The Journal of Allergy and Clinical Immunology, 126, 712–721.
Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., et al. (2011). TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. The International Journal of Biochemistry & Cell Biology, 43, 154–162.
Cieslik, K. A., Taffet, G. E., Carlson, S., Hermosillo, J., Trial, J., & Entman, M. L. (2011). Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. Journal of Molecular and Cellular Cardiology, 50, 248–256.
Friedrich, K., Brändlein, S., Ehrhardt, I., & Krause, S. (2003). Interleukin-4- and interleukin-13 receptors trigger distinct JAK/STAT activation patterns inmouse lymphocytes. Signal Transduction, 1–2, 26–32.
Ingram, J. L., Rice, A. B., Geisenhoffer, K., Madtes, D. K., & Bonner, J. C. (2004). IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. The FASEB Journal, 18, 1132–1134.
Haudek, S. B., Gupta, D., Dewald, O., Schwartz, R. J., Wei, L., Trial, J., et al. (2009). Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovascular Research, 83, 511–518.
Medina, A., & Ghahary, A. (2010). Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts. Molecular Cell Biochem, 344(1–2), 11–21.
Wang, J. F., Jiao, H., Stewart, T. L., Shankowsky, H. A., Scott, P. G., & Tredget, E. E. (2007). Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair and Regeneration, 15, 113–121.
Liao, W. T., Yu, H. S., Arbiser, J. L., Hong, C. H., Govindarajan, B., Chai, C. Y., et al. (2010). Enhanced MCP-1 release by keloid CD14+ cells augments fibroblast proliferation: role of MCP-1 and Akt pathway in keloids. Experimental Dermatology, 19, e142–e150.
Haudek, S. B., Cheng, J., Du, J., Wang, Y., Hermosillo-Rodriguez, J., Trial, J., et al. (2010). Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 49, 499–507.
Chen, G., Lin, S. C., Chen, J., He, L., Dong, F., Xu, J., et al. (2011). CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. Journal of the American Society of Nephrology, 22, 1876–1886.
Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Michael, L. H., et al. (2005). CCL2/monocyte chemoattractant protein (MCP)-1 regulates inflammatory responses critical to healing myocardial infarcts. Circulation Research, 96, 881–889.
Bujak, M., Kweon, H. J., Chatila, K., Li, N., Taffet, G., & Frangogiannis, N. G. (2008). Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. Journal of the American College of Cardiology, 51, 1384–1392.
Gould, K. E., Taffet, G. E., Michael, L. H., Christie, R. M., Konkol, D. L., Pocius, J. S., et al. (2002). Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. American Journal of Physiology - Heart and Circulatory Physiology, 282, H615–H621.
Thakker, G. D., Frangogiannis, N. G., Bujak, M., Zymek, P., Gaubatz, J. W., Reddy, A. K., et al. (2006). Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. American Journal of Physiology - Heart and Circulatory Physiology, 291, H2504–H2514.
Goldsmith, E. C., Hoffman, A., Morales, M. O., Potts, J. D., Price, R. L., McFadden, A., et al. (2004). Organization of fibroblasts in the heart. Developmental Dynamics, 230, 787–794.
Cieslik, K. A., Trial, J., & Entman, M. L. (2011). Defective mesenchymal stem cell differentiation in aging murine heart: rescue by Tak1/AMPK/p38 MAPK pathway. American Journal of Pathology, 179, 1792–1806.
Acknowledgments
This work is supported by National Institutes of Health RO1 HL-089792 (MLE), the American Heart Association 10SDG4280031 (SBH), the Hankamer Foundation, and the Medallion Foundation. The authors wish to thank Ms. Sharon Malinowski for her editorial assistance with the manuscript.
Ethical Considerations
The Guide for the Care and Use of Animals was followed when performing the experiments described in this paper. The experiments performed comply with the current laws of the country in which they were performed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crawford, J.R., Haudek, S.B., Cieslik, K.A. et al. Origin of Developmental Precursors Dictates the Pathophysiologic Role of Cardiac Fibroblasts. J. of Cardiovasc. Trans. Res. 5, 749–759 (2012). https://doi.org/10.1007/s12265-012-9402-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9402-7